The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan Hsiu-Hao ChangMeng-Yao LuKai-Hsin Lin Original Article Open access 25 September 2015 Pages: 1945 - 1952
Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes Pallavi R. MehtaDipti S. UpadhyeRoshan B. Colah Original Article 29 August 2015 Pages: 1953 - 1958
Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5′-maleimide binding assay Oliver AndresStefan EberChristian P. Speer Original Article 04 September 2015 Pages: 1959 - 1964
Association of GSTM1 and GSTT1 deletion polymorphisms with Pakistani aplastic anemia patients and controls and meta-analysis Sadia RehmanParvez AhmedAtika Mansoor Original Article 01 September 2015 Pages: 1965 - 1971
Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia Marc MichelJeffrey WasserXuena Wang Original Article 04 September 2015 Pages: 1973 - 1980
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013) Theo de WitteStefan SuciuFrédéric Baron Original Article Open access 26 September 2015 Pages: 1981 - 1989
Evaluation of IDH1G105 polymorphism as prognostic marker in intermediate-risk AML Annette FasanClaudia HaferlachSusanne Schnittger Original Article 09 September 2015 Pages: 1991 - 2001
Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG) Heiko BeckerStefan SuciuMichael Lübbert Original Article 24 September 2015 Pages: 2003 - 2013
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML Alice FabariusLida Kalmantifor the SAKK and the German CML Study Group Original Article 18 September 2015 Pages: 2015 - 2024
Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings Myron S. CzuczmanA. GoyR. H. van der Jagt Original Article 28 September 2015 Pages: 2025 - 2032
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience Eirini KatodritouEvangelos TerposMeletios-Athanasios Dimopoulos Original Article 30 September 2015 Pages: 2033 - 2042
Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma Nobuhiko NakamuraTakeshi HaraHisashi Tsurumi Original Article 19 September 2015 Pages: 2043 - 2053
Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation Noriko DokiKyoko HaraguchiKazuteru Ohashi Original Article 04 September 2015 Pages: 2055 - 2060
Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab Kei MuroiMamiko Sakata-YanagimotoShigeru Chiba Letter to the Editor 04 August 2015 Pages: 2061 - 2062
Lower gastrointestinal bleeding in a patient with Crohn’s disease and plasma cell leukemia in remission Karin G. SchrenkKathrin KatenkampSebastian Scholl Letter to the Editor 21 August 2015 Pages: 2063 - 2065
Hyperleukocytosis in acute myeloid leukemia patients is associated with high 30-day mortality which is not improved with leukapheresis Gee Chuan Wong Letter to the Editor 09 August 2015 Pages: 2067 - 2068
Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome Jianlin QiaoAmanda K. DavisRobert K. Andrews Letter to the Editor 16 August 2015 Pages: 2069 - 2071
Oral beclomethasone dipropionate as an initial treatment for stages 1–2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation Hisashi YamamotoNaoyuki UchidaShuichi Taniguchi Letter to the Editor 16 September 2015 Pages: 2073 - 2075
Safe utilization of ibrutinib with or without steroids in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia Rosanne St. BernardCyrus C. Hsia Letter to the Editor 03 September 2015 Pages: 2077 - 2079
Enhanced formation of neutrophil extracellular traps in patients with graft versus host disease Jianlin QiaoFeng ZhuLingyu Zeng Letter to the Editor 07 September 2015 Pages: 2081 - 2083